title: Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Keating
authors.forename: A  James
authors.initials: A
authors.lastname: O'Malley
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Freedland
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Smith
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000453:epidemiology* / Q000209:etiology; D003327:Coronary Disease / Q000139:chemically induced / Q000453:epidemiology; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced / Q000453:epidemiology; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced / Q000453:epidemiology; D016017:Odds Ratio; D009919:Orchiectomy / Q000009:adverse effects; D016016:Proportional Hazards Models; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D020521:Stroke / Q000139:chemically induced / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D014728:Veterans / Q000706:statistics & numerical data*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone